Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
-
Page/Page column 00299-00300
(2019/09/18)
INHIBITION OF OLIG2 ACTIVITY
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
-
Paragraph 00501-00502
(2018/03/25)
Pyrazolopyridine compound and use thereof
The present invention relates to a pyrazolopyridine compound and use thereof, and further relates to a pharmaceutical composition comprising the pyrazolopyridine compound. The pyrazolopyridine compound or the pharmaceutical composition can be used as a so
-
Paragraph 0476; 0478; 0479
(2018/11/03)
Pyridonecarboxylic acids as antibacterial agents. VIII. An alternative synthesis of enoxacin via fluoronicotinic acid derivatives
-
Miyamoto,Egawa,Matsumoto
p. 2280 - 2285
(2007/10/02)
More Articles about upstream products of 1652-39-7